BackgroundCheck.run
Search For

Stephen R Sofen, 713 Abernathy Rd, Lexington, MA 02420

Stephen Sofen Phones & Addresses

3 Abernathy Rd, Lexington, MA 02420    781-8618532   

Brunswick, ME   

Social networks

Stephen R Sofen
Stephen R Sofen

Linkedin

Work

Company: Abata therapeutics Position: Chief technical officer

Education

School / High School: University of Virginia Darden School of Business 1994

Skills

Technology Transfer • Biotechnology • Biopharmaceuticals • Pharmaceutical Industry • Gmp • Drug Development • Life Sciences • R&D • Product Development • Fda • Commercialization • Manufacturing • Chemistry • Cross Functional Team Leadership • Process Simulation • Medical Devices • Protein Chemistry • Drug Discovery • Validation • Oncology • Strategy • Project Management • Quality Assurance • Clinical Trials • Strategic Planning • Research and Development • Nda • Lifesciences • U.s. Food and Drug Administration • Process Development • Cgmp • Pharmaceuticals

Emails

Industries

Biotechnology

Mentions for Stephen R Sofen

Stephen Sofen resumes & CV records

Resumes

Stephen Sofen Photo 4

Chief Technical Officer At Abata Therapeutics

Location:
3 Abernathy Rd, Lexington, MA 02420
Industry:
Biotechnology
Work:
Abata Therapeutics
Chief Technical Officer
Sofen Consulting
Principal
Crispr Therapeutics Mar 2016 - Mar 2018
Vp, Process Development and Manufacturing
Kaleido Biosciences, Inc. Mar 2016 - Mar 2018
Senior Vice President Techical Operations
Kiniksa Pharmaceuticals Nov 2015 - Mar 2016
Vp, Cmc
Biogen Jul 2013 - Oct 2015
Cmc Team Director
Massachusetts Institute of Technology (Mit) Sep 2011 - Jul 2013
Executive Director, Novartis-Mit Center For Continuous Manufacturing
Sanofi Genzyme Apr 2009 - Sep 2011
Vice President, Manufacturing Operations Project and Product Management
Sanofi Genzyme Apr 2005 - Mar 2009
Vice President, Therapeutics Operations Project Managment
Sanofi Genzyme Apr 2002 - Mar 2005
Senior Director, Therapeutics Manufacturing and Development
Sanofi Genzyme Apr 2001 - Mar 2002
Director, Project Management, Therapeutics Manufacturing and Development
Procter & Gamble 1998 - 2001
Director
Polaroid 1979 - 1998
Senior Director, R and D Lab Mgr., Senior Scientist, Scientist
Education:
University of Virginia Darden School of Business 1994
University of California, Berkeley 1975 - 1979
Doctorates, Doctor of Philosophy, Chemistry
Reed College 1971 - 1975
Bachelors, Bachelor of Arts, Chemistry
Graduate School of Business & Administration
Skills:
Technology Transfer, Biotechnology, Biopharmaceuticals, Pharmaceutical Industry, Gmp, Drug Development, Life Sciences, R&D, Product Development, Fda, Commercialization, Manufacturing, Chemistry, Cross Functional Team Leadership, Process Simulation, Medical Devices, Protein Chemistry, Drug Discovery, Validation, Oncology, Strategy, Project Management, Quality Assurance, Clinical Trials, Strategic Planning, Research and Development, Nda, Lifesciences, U.s. Food and Drug Administration, Process Development, Cgmp, Pharmaceuticals

Publications & IP owners

Us Patents

Thermographic And Photothermographic Imaging Materials

US Patent:
5328799, Jul 12, 1994
Filed:
Jun 17, 1993
Appl. No.:
8/079146
Inventors:
James R. Freedman - Newton Centre MA
Stephen R. Sofen - Lexington MA
Kent M. Young - Carlisle MA
Assignee:
Polaroid Corporation - Cambridge MA
International Classification:
G03C 554
US Classification:
430200
Abstract:
Photothermographic and thermographic diffusion transfer image-recording materials are provided wherein an auxiliary ligand for silver ions is employed to enhance transfer image density and discrimination.

Stabilization Of Thermal Images

US Patent:
5206208, Apr 27, 1993
Filed:
Nov 20, 1991
Appl. No.:
7/795101
Inventors:
Rong C. Liang - Lexington MA
William C. Schwarzel - Billerica MA
Rita S. Shon Baker - Brookline MA
Robert P. Short - Arlington MA
Stephen R. Sofen - Lexington MA
Michael A. Young - Natick MA
Assignee:
Polaroid Corporation - Cambridge MA
International Classification:
B41M 530
US Classification:
503201
Abstract:
The addition, to a thermal imaging medium comprising a color-forming compound which undergoes a change of color upon heating above a color-forming temperature for a color-forming time, the color-forming compound being of the cyclic sulfonamide type described in U. S. Pat. Nos. 4,720,449 and 4,960,901, of a source of zinc, nickel, copper(II), cobalt(II) or aluminum(III) cations increases the sensitivity of the imaging medium and helps to prevent fading of images produced therefrom while the images are being projected.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.